AHSG and COVID-19: Meanwhile, the negative acute-phase reactant fetuin-A (FETUA) and APOM were reduced in COVID-19 patients, suggesting that their reduction is caused by the exacerbated innate immune response to the SARS-CoV-2 infection [27,28].